[McArdle disease or glycogen storage disease type v: Should it affect anaesthetic management?]

V Ayerza-Casas1, L Ferreira-Laso1, M C Alloza-Fortun1

  • 1Servicio de Anestesiología, Reanimación y Terapéutica del dolor, Hospital San Pedro de Logroño, Logroño, España.

Insights

McArdle disease, a metabolic myopathy, can cause serious perioperative issues. Careful management and preventive strategies are crucial for patients undergoing surgery, such as mastectomy, to avoid complications.

Area of Science:

  • Metabolic Myopathies
  • Clinical Case Reports
  • Perioperative Medicine

Background:

  • McArdle disease is a rare genetic disorder affecting muscle energy metabolism.
  • Patients with McArdle disease are at increased risk for perioperative complications due to impaired glycogenolysis.
  • This case highlights the importance of specialized anesthetic and surgical planning for these patients.

Observation:

  • A patient with a known history of McArdle disease was scheduled for a mastectomy.
  • The case underscores the potential for severe perioperative problems in individuals with this metabolic myopathy.
  • Close monitoring and tailored interventions are necessary during the perioperative period.

Findings:

  • Understanding the specific physiological challenges of McArdle disease is key to preventing adverse events.
  • Proactive management strategies, including appropriate fluid and carbohydrate administration, can mitigate risks.
  • Successful surgical outcomes are achievable with meticulous perioperative care.

Implications:

  • This case report emphasizes the need for multidisciplinary collaboration in managing patients with McArdle disease.
  • Anesthesia and surgical teams should be educated on the specific perioperative risks associated with metabolic myopathies.
  • Implementing standardized protocols for McArdle disease patients can improve surgical safety and patient outcomes.

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
477
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
457
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
936
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342